-
Product Insights
Minut Solar PV Park
Minut Solar PV Park is a solar PV project located in North Sulawesi, Indonesia. The project is owned and developed by Vena Energy Pte Ltd. The project came online in 2019. Empower your strategies with our Minut Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval Analysis for Status Epilepticus
Overview How likely is it that the drugs in Status Epilepticus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Status Epilepticus Overview Status epilepticus is an emergency neurological condition where seizures...
-
Product Insights
NewLikelihood of Approval Analysis for Peanut Allergy
Overview How likely is it that the drugs in Peanut Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peanut Allergy Overview Peanut allergy is common, especially in children. An allergic...
-
Product Insights
NewLikelihood of Approval Analysis for Pollen Allergy
Overview How likely is it that the drugs in Pollen Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pollen Allergy Overview Pollen allergy, characterized by sensitivity to the minute particles...
-
Product Insights
NewLikelihood of Approval Analysis for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Overview How likely is it that the drugs in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Acute Myelocytic Leukemia...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Secondary Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Secondary Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Secondary Acute Myeloid Leukemia Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Metastatic Colorectal Cancer Drug Details: Siremadlin succinate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Myelofibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Myelofibrosis Drug Details: Siremadlin succinate (HDM-201) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Siremadlin Succinate in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Siremadlin Succinate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Siremadlin Succinate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details:...